A Clinical Study On: Diagnostic Methdology of Paandu
A Clinical Study On: Diagnostic Methdology of Paandu
A Clinical Study On: Diagnostic Methdology of Paandu
Dissertation submitted To
THE TAMIL NADU DR.M.G.R. MEDICAL UNIVERSITY,
Chennai – 32.
CERTIFICATE
Date:
BONAFIDE CERTIFICATE
This is to certify that the dissertation entitled “ A CLINICAL STUDY ON
DIAGNOSTIC METHODOLOGY OF PAANDU (ANAEMIA)-
THROUGH SIDDHA PARAMETERS” is a bonafide work done by DR.
MURUGAMOORTHY THUSIYANTHAN (Reg No –321615008),
GOVERNMENT SIDDHA MEDICAL COLLEGE AND HOSPITAL,
PALAYAMKOTTAI in a partial fulfillment of the university rules and
regulations for award for MD (S) NOINAADAL under my guidance and
supervision during the academic year 2016 – 2019.
Name and Signature of Guide :
First and foremost, I thank the “ Almighty God” who’s always been
as strength wisdom and guides throughout the process of bringing out my
Dissertation work successfully.
I would like to extend my thanks to Siddhars, because of their
blessing to complete this work.
I heartfelt thanks my Parents and family members for giving me
this opportunity and the blessings to fulfill this work.
1
Paandu (Anaemia is a disease with known diagnosis and prognosis will be
selected for the study. Siddha science has placed Anaemia not as a state or
condition but a disease. In Siddha, the term Paandu may be used instead of
Anaemia, Paandu is otherwise called Velluppunoi, Venpandu, etc. In this disease
the body, conjunctiva, nail bed, oral mucosa etc, appears pallor. There are six type
of paandu. Three are caused due to derangement of a specific humour Vatham or
Pitha or Kapham. One of the classifications is caused due to derangement of the
three humours together known as the Mukkutrap paandu. Another one type is
caused due to toxic manifestation in blood known as Nanju Paandu. This type is
incurable one. The last one is cause………………8
According to Agasthiar Gunavahadam stated about Paandu is,
( mf];jpaH Fzthflk;)
In the script of Siddha the disease is the result of increased Pitham. The following
procedures, taken for the study namely Neikkuri, Eight fold examinations and
Manikkadai Nool (wrist circummetric sign) will be considered for this study. The
treatment in traditional system will be more valid if the disease is diagnosed by
its own perspective. So the present study will be carried out to validate the Siddha
diagnostic procedure for Paandu.
A large numbers of patients especially women and children are seen with
pale look and shining appearance, which are some land marks of under
nourishment Siddha system defines this condition as “Paandu noi” or “Veluppu
noi”.
So, around the world malnutrition and blood loss are the most common
cause for iron and B12 deficiency anaemia.
3
AIM AND OBJECTIVES
AIM
OBJECTIVE
Primary Objectives
Secondary Objectives
4
ELUCIDATION OF DISSERTATION TOPIC PAANDU
“ ghulh ghz;Ltif nrhy;yf; Nfsha;
( mf];jpaH Fzthflk;)
nghJ FwpFzq;fs;
5
mtHeilAk; jsHe;J ngU%r;Rf; fz;L
%Nkjhd; %Hr;irAld; khh; Jbj;J
Kbthd fZf;fhypy; tPf;f Kz;lha;
J}Nkjh dpujaj;jpd; tjde; jd;dpw;
JUj;jpepfh; rj;jkJ Nfl;Fk; ghNu”
mfj;jpah; Fzthflk;
tha;g;Gz; : Stomatitis
grpapd;ik : Annorexia
glglg;G : Palpitation
Nrhk;gy; : Lassitute
6
REVIEW OF LITERATURE
SIDDHA ASPECT
1. SIDDHA PHYSIOLOGY
96 jj;Jtq;fs;
07 clw;jhJf;fs;
14 Ntfq;fs;
04 cly; jP
1.1 . njhz;Z}w;whW jj;Jtq;fs;
Kjy; jj;Jtk; 30
,uz;lhk; jj;Jtk; 30
%d;whk; jj;Jtk; 36
vd;wthwhf 96 jj;Jtq;fSk; tifg;gLj;jg;gl;Ls;sd.
7
1.2 cly; jhJf;fs; 07
ekJ cly; VO cly; jhJf;fshy; cUthdJ. rhuk;> nre;ePH> Cz;>
nfhOg;G> vd;G> %is > Rf;fpyk;, RNuhzpjk;. ,e;j VO jhJf;fSk;
clypid ed;dpiyapy; itf;f cjTfpd;wJ.
1.3 Ntfk; 14
“ gjpdhd;F Ntfg; ngaHfs;
gfHe;jplNt mtw;iwf; Nfsha;
tpjpj;jpLk; thjk; Jk;ky;
NkTePH kyk; nfhl; lhtp
fjpj;jpL grpePH Ntl;if
fhrNkh bisg;G epj;jpiu
kjpj;jpL the;jp fz;zPH
tsHRf;fpyQ; RthrkhNk”
8
1.4 cly; jP ehd;F
rkdhf;fpdp
ke;jhf;fpdp
jPf;rhf;fpdp
tp\khf;fpdp
ghz;L Neha;
NtW ngaHfs;
ntSg;G Neha;> ntz;ik Neha;> ntz; ghz;lk;
,ay;
gjhHj;j rpe;jhkzp
9
ghz;L Nehapd; tiffs;
rpj;jkUj;Jt E}y;fspd; mbg;gilapy; ghz;L Nehapd; tiffs;
gythwhf tifg;gLj;jg;gLfpd;wd. mit tUkhW>
1. mfj;jpaH Fzthflk ; 05
thjg; ghz;L
gpj;jg; ghz;L
fgg; ghz;L
kpUj;jpf ghz;L
tp\g;ghz;L
3. jd;te;jpup itj;jpak; 07
thjg; ghz;L
gpj;jg; ghz;L
fgg; ghz;L
Kf;Fw;wg;ghz;L
gpj;jthjg; ghz;L
rd;dpthjg; ghz;L
igj;jpag; ghz;L
4. T.V rhk;grptk;gps;is 06
thjg; ghz;L
gpj;jg; ghz;L
fgg; ghz;L
Kf;Fw;wg; ghz;L
CJ ghz;L
ePHg; ghz;L
10
5. itj;jpa rhu rq;fpufk; 05
thjg; ghz;L
gpj;jg; ghz;L
%yg; ghz;L
%ygpj;jg; ghz;L
tplg; ghz;L
6. guuhrNrfuk; 05
thjg; ghz;L
gpj;jg; ghz;L
fgg; ghz;L
rd;dpg; ghz;L
kpUjpfhg; ghz;L
11
10. [Pt uf;rhkpHjk; 05
thjg; ghz;L
gpj;jg; ghz;L
fgg; ghz;L
jpupNjhrg; ghz;L
kpUjpfhg; ghz;L
2. SIDDHA PATHOLOGY
Neha;ehly;
rpj;j kUj;Jt Kiwapy; Nehapid Kf;Fw;w mbg;gilapy;> thj>
gpj;j> fgkhfg; gpupj;Js;sdH. ekJ kUj;Jt Kiw #f;Fk clYf;Fk; J}y
clYf;Fk; kUj;Jt topKiw te;Js;sJ.
nghJf; FwpFzk;
ntg;gk;
$Hik
nea;g;G
nefpo;rr; p
gpj;jk; ve;jg; nghUSld; NrUfpwNjh mJ mjd; Fzj;ij milAk;.
,aw;iff; Fzq;fs;
nrupj;jy;
td;ik
ntk;ik
nkd;ik
ghHit
ePHNtl;if
grp
xsp
Rit
epidg;G
mwpT
mf;fpdp FspHr;rp
Gspg;G ,dpg;G
CWk; jd;ik epiyj;jpUj;jy;
fhuk; ifg;G
F&uk; rhe;jk;
ry&gk; nfl;b
13
gpj;jj;jpd; njhopy;fs;
1. clypw;F kQ;rs;> nre;epwk; nfhLj;jy;
2. cly; ntg;gj;ij mjpfupf;Fk;
3. nrupkhdj;jpy; cly; ntg;gj;ij mjpfupj;jy;
4. tpaHit cz;lhf;fy;
5. ,uj;jj;ij mjpfupj;jy; kw;Wk; ntspj;js;sy;
6. Gspg;Gr;Rit jUjy;
7. Nfhgk;> epiyapy;yhJ ,Uj;jy;
8. fz;> kyk;> rpWePUf;F kQ;rs; epwk; jUjy;
Ritabg;gilapy; – gpj;jk;
cg;G jP ePH
Gspg;G kz; jP
fhHg;G fhw;W jP
14
2.2 Kf;Fw;w NtWghL
cly; td;ik Fiwe;J grpj;jP (mdw; gpj;jk;) Nflile;J cz;l czT
rupahf nrupahky; NghFk;.
thjk;
thjk; thOkplk;
mghdd;> kyk;> ce;jpapd; fPo; %yk;> euk;Gf; $l;lk;> Cd;> gf;Fthrak;>
fhJ
,aw;ifg; gz;G
Cf;fKz;lhf;fy;
%r;Rtply; thq;fy;
kdnkhop nra;fSf;Fr; nraiyj;juy;
kyk; Kjypa gjpdhd;F tpiuTfis ntspg;gLj;jy;
rhuk; Kjypa VO clw fl;Lfl;Fk; xj;j epfo;rr
; piaj;juy;
Ik;nghwpfl;F td;ikiaf; nfhLf;Fk;.
tiffs; 10
1. gpuhzd;
ghz;L Nehapy; %r;Rtpl rpukk;> czT nrupahik Vw;gLk;
2. mghdd;
ghz;L Nehapy; cztpd; rhuk; NruNtz;ba ,lq;fspy; NrHg;gpf;fhJ.
fopr;ry; kyf;fl;L rpWePh;f; FiwT Vw;gLk;.
15
3. tpahdd;
ghz;L Nehapy; cly; tPf;fk;> fz; cjL ntSj;jy; cz;lhFk;.
4. cjhdd;
ghz;L Nehapy; mjpf ePH Ntl;if cz;lhFk;.
5. rkhdd;
ghz;L Nehapy; grpapd;ik Vw;gLk;
6. ehfd;
,ay;G
7. $Hkd;
,ay;G
8. fpUfud;
grpapd;ik cz;lhFk;
9. Njtjj;jd;
ghz;L Nehapy; J}f;fkpd;ik cz;lhFk;
10. jdQ;nrad;
ghz;L Nehapy; ghjpg;gilahJ.
gpj;jk;
gpj;jk; thOkplk;
gpq;fiy> ePHg;ig> Koq;if> ,Ujak;> jiy> nfhg;G+o;> ce;jp>
gpuhzthA> ,iug;ig> tpaHit> ehtpy; CWk; ePH> nre;ePH> ruk;> fz;>
Njhy;.
1. mdw;gpj;jk;
ghz;L Nehapy; grpapd;ikia cz;lhf;Fk;
2. gpuhrf gpj;jk;
ghz;L Nehapy; fz;> Njhy; ntSj;jy;
3. ,uQ;rf gpj;jk;
ghz;L Nehapy; fz;> Njhy; ntSj;jy;
4. MNyhrf gpj;jk;
,ay;G
5. rhjf gpj;jk;
ghz;L Nehapy; njhopy;ruptu nra;aKbahky; cly; NrhHT cz;lhjy;.
16
fgk;
,Uf;Fkplk;
rkhdthA> tpe;J> jiy> ehf;F> nfhOg;G> vYk;G k[;i[> FUjp> khHG>
%f;F> euk;G> vYk;G>%is> fz; kw;Wk; %l;Lf;fs;.
1. mtyk;gfk;
ghz;L Nehapy; %r;Rj; jpzwy; cz;lhFk;.
2. fpNyjfk;
ghz;L Nehapy; grpapd;ik cz;lhFk;.
3. Nghjfk;
ghz;L Nehapy; grpapd;ik> Ritapd;ik cz;lhFk;
4. jw;gfk;
,ay;G
5. re;jpfk;
,ay;G
TABLE - 01
2.4 epyk;
FwpQ;rp> nea;jy; kw;Wk; ghiy epyq;fspy; thOk; kf;fSf;F ghz;L Neha;
tUtjw;fhd tha;g;Gf;fs; mjpfk;.
17
3. SIDDHA PATHOGENESIS
Pathologically, blood loss may occur due to various causes. One among them
is worm infestation, which leads to chronic blood loss from the intestine – hence
causes Anaemia.
20
nghUkptUk; thAnty;yhq; fpUkpahNy
GOf;fbNghy; fhZkJ fpUkpahNy
According to this Sobai will occur due to worm infestation which meant Pandu
noi.
Congenital, neonatal diseases are due to parental factors. Pandu may also
occur as genetic disorders.
21
ngz;fSf;F khjtplha;f; NfhshwpdhYk; Vw;gLk;. ,e;Neha; gpwtp
NehahAk; ,Uf;fyhk;. Nkf rk;ge;jkhd fpue;jp Kjypa Neha;fs;> Nrhif
Neha; ,itfshYk; cz;lhfyhk;.
In his opinion, pandu means only venmai (pallor) refers merely to anaemia
where the patient turns pale or white.
Therayar vaagadam says that thorns of fish , paady bran, bone, stones,old rice,
hair in food are the dietary factors causing Pandu. Then severe constipation,
drinking polluted water, sleeping in an abnormal posture are all the causes that
bring out Pandu noi.
Here it is explained that Pandu and other diseases occur due to the toxic
substance produced in the body by their unhealthy life style.
22
gjpndz; rpj;jHfs; ehb E}y; vd;w E}ypy; Neha;tUk; top
njhlh;ghf gpd;tUkhW $wg;gLfpd;wJ
nfhs;s………”
The pitha Theghi may get emaciated and later the body becomes pale. More
over excess intake of sour food stuffs results in pandu noi.
23
khWgl;L ghz;LNuhfj;ij cz;lhf;Ffpd;wJ. ,jid tp\g;ghz;L vd;Wk;
$Wth;.
gjhHj;j Fzk; vd;w E}ypy; Neha;tUk; top njhlh;ghf
gpd;tUkhW $wg;gLfpd;wJ.
There is an evidence that the Kurunchi nilam, the hills and its surrounding
areas are endemic for Pandu noi
24
3.2 ghz;L Neha; FwpFzq;fs;
3.2.1 Kw;FwpFzq;fs;
mjpfkhd cly;NrhHT
%r;Rtpl rpukk;
fz;ghHit
xspFd;wy;
kaf;fk;
khHG glglg;G
cly; ntSj;jy;
vd;gd cz;lhf;Fk;.
25
kaf;fk;> ,ja ehb Fiwjy;> Ntiyapd; NghJ %r;Rj;jpzwy;> tpop
gpJf;fk;> fZf;fhy; tPf;fk;> JUj;jp epfH xsp vd;gd cz;lhFk;.
,e;Nehapy; cly; td;ik ehSf;F ehs; Fiwe;J elf;f ,ayhik> jiy
Nehjy;> kaf;fKz;lhjy;> %r;Rj;jLkhwy;> grpj;jP nfly;> czT
Ntz;lhik> cz;l rpW czTk; the;jpahjy; Mfpa Fwpfs;
Njhd;Wk;. ,d;Dk; kpfTk; ntSj;Jj; Njhy; RUf;fy;> cly; nkype;J
gsgsj;J ntSg;ghjy;> eff; fZf;fs; jbj;J ntSj;jy;> eh ntbj;Jg;
Gz;zhjy; my;yJ ehtpd; Nkw; Njhiyr; rPtpnaLj;jJ Nghd;W
rPtpnaLj;jJ Nghd;W rpte;J fhZjy;> njhz;il fl;Ljy; vd;Dk;
FwpfSk; fhZk;.
-ghythflk;
26
3.3; rpj;j kUj;Jt E}y;fspd; mbg;gilapy; Neha;
FwpFzq;fs;
27
“ Njhd;Wk; tha;f;frg;G NkjpAw;w ehbAk;
fgg; ghz;L
28
“ Nth;j;J ntJk;Gq; fz;FspUk;Ntr; nrd;wpUf;Fk; tpyhTk; neQ;Rkhj;
29
“ cz;lhFk; NghjpdpNy Njf NeHik
tpr ghz;L
rjpnra;A
; k; the;jptpf;fy; ,Uky; fz;L
30
Hic cough
Cough
Hallucination
General oedema
Anorexia
3.3.2 A+fpitj;jparpe;jhkzp
thj ghz;L
gpj;jg; ghz;L
fgg; ghz;L
fPwpaNjhH euk;GNjhy; kpf ntSg;G
32
Sneezing
Cough with expectoration
Fainting
Lassitude
Emission of semen
Kf;Fw;wg; ghz;L
jpg;gNt Njfnkq;FkrjpahF
Anorexia
Anasarca
Dyspnoea
Emaciation
Hot urine
Lassitude
Chest pain
Warmness of the skin
Sneezing
Weakness
tprg;ghz;L
fgg; ghz;L
“ tFj;jpbw; rf;jpAz;lh kw;WNk aUrpAz;lh
Vomiting
Anorexia
Dyspnoea
Anasarca
Pallor of the skin and nail
Diminished volume of pulse
Kf;Fw;wg; ghz;L
35
jpiue;Jly;fLf;Fk; tpaHf;Fe;jpupNjhr ghz;Lntd;Nw (9)
Pedal oedema
oedema of arms,face and eyes
Dyspnoea
Vomiting
Chest pain
Frothy urine
Black or yellow coloured nail
body pain
Excessive sweating
rd;dpthj ghz;L
36
NgJw;W kyryq;fs; efq;fSq; fWg;Gf; nfhs;Sk;
Pain
Shivering
Heaviness
Pallour of the body
Anasarca
Blackish urine, fecies, nail
Distended abdomen
Anorexia
Pallor of the eyes, tongue, lips, skin
Pain in both extremities
Swelling of eyes and face
Frothy and watery stool
Hatedness of food
gpj;jg; ghz;L
37
“,UkNy apisg;G neQ;rp ypbg;gpld; Wug;G khfpg;
rpNyw;gd ghz;L
“nka;Na ntspWk; tapwijf;Fk; tPq;Fk; Gwq;fhy;Gwq;iffsp
38
“ NtHj;J ntUtpf;fz FspUk;ntr; nrdpwpUf;Fk; tpy;neQ;Rk;
rd;dpg; ghz;L
40
kpUj;jpfh ghz;L
NtnwhU tif 03
Rughz;L
fever
drowsiness
giddiness
hatedness of food
Evening cough
distented abdomen
Excessive thirst
Hot micturation
greenish stool
41
uj;j ghz;L
fever
headache
Haematemesis
Weakness of the lower limbs
Oedema of eyes and face
Excessive salaivation
Heartburn
Redness of urine and faeces
Tinnites
Emaciation
Nausea
Melanoptysis
Distended abdomen
%yghz;L
#y Nkw;nfhz;LzT RUq;fpLk;
gpj;jg; ghz;L
Yellow coloured nails, eyes,urine, faeces
Excssive thirst and sweat
Desire to cold substances
Bad breath
Pungent taste
Hallitosis
43
Constipation
Eructation
Yellowish colouration of the body
Chest pain
Dyspnoea
Giddiness
fgg; ghz;L
White colour of eyes, urine and faecies
Laziness
Tiredness
Salty taste
Sore throat
Horropillation
Vomiting
Sneezing
Giddiness
Cough with expectoration
Ejaculation of sperm
Kf;Fw;wg;ghz;L
The all symptoms of above classification occurs along with
Dyspnoea
Chest pain
Obesity
tiredness
kpUj;jpfh ghz;L
Due to excessive intake of mud ,rasam , and raktha thathu becomes weak and
result Pandu noi.
Constipation
Haematamesis
Oedema of umbilicus, pedal, face, external genetalia
44
tplg; ghz;L
If above pandu’s are not treated properly
Anorexia
Thirst
Warmness of the body
Dyspnoea
Diarrhoea
Cough
Vomiting
Hic cough
Tiredness of the chest
Pyrexia
Yellow or paleness of the skin
It is incuarable
gpj;jg; ghz;L
Yellow or juicey green colour of blood vessels
Fever
Thirst
Over sweating
Dimnished vision
45
Fainting
Yellow colour of the body
Pungent taste even at sleep
pyrexia
Coated tongue
Eructation
Bitter taste
Constipation
Giddiness and dyspnea
fgg; ghz;L
Pallor of the blood vesselse
sour taste
Cough
Sore throat
Sneezing
Vomitting
Syncope
Dyspnoea
Burning sensation
jpupNjhrg; ghz;L
It consists of the charecters of Vatha, Piththa, Kapha pandu associated with
anasarca and general debility
kpUj;jpfh ghz;L
Pervertion of appetide in the form of the geophagia.
Derangement of Vatha, Piththa, Kapha
Affects the digestive system
Piththa thathu is mainly affected by the agni in the stomach, results dryness of the
rasathathu.
Leads to improper formation of raththa thathu
46
Swelling around the umbilicus, face, legs and genital organs , worms in the faeces,
cough with expectoration, with blood tinch
47
gytPdk;> the;jp> %Hr;ir> mjpf ehshd ghz;L Nuhfk; rpfpr;irf;F
trg;glhJ GjpjhdhYk; cly; eh twl;rp> ,uj;jf; Fiwtpdhy; cly;
ntSg;G KjypaitfSld; $ba NuhfpAk; FzkiltJ rpukk;.
gw;fs;> efk;. fz; ,itfs; mjpfk; ntSj;jhYk; vy;yhtw;iwAk;
ntz;zpwkhfg; ghHj;jhYk; me;j Nuhfk; mrhj;jpakhFk;.
iffs;> fhy;fs;>jiy Kjyhd ,lq;fspy; tPf;fk; Vw;gl;L ,isj;J if
fhy;fSk; ,isj;J tapW ngUj;Jk; cs;s ghz;L NuhfpiaAk;> Mz;Fwp>
njhil ,Lf;F Mfpa ,lq;fspy; tPf;fk;> mbf;fb kaf;fk;> mjprhuk;>
Ruk; Mfpad fz;L tUk; NuhfpiaAk; Fzg;gLj;JtJ mrhj;jpak; MFk;.
4.7 fz;Zrhkpak;
“ nrhy;Y gpj;jj;jpw; Nrhig Nrhigjdpy; thA njhe;jk;
ty;ytjpw; ghz;Ltd; ghz;by; - ey;y
5.1 nghwpahywpjy;
Njhy; - if> fz;> eff;fz; ntSj;jy;
eh - nkd;ikahd gOg;G epwkhd gsgsg;ghd ehf;F.
fz; - nts;tpop ntSj;jy;
%f;F - ,ay;G
fhJ - ,ay;G
5.2 Gydhywpjy;
Rit - Ritapd;ik
ghu;it - kq;fpa ghHit
CW - Njhy; twl;rp
xyp - fhJ ,iur;ry;
kzk; - ,ay;G
49
5.3 tpdhTjy;
Nehahspapd; ngaH > taJ> njhopy;> ,lk;> FLk;g #o;epiy FLk;g
tuyhW> Nehapd; fhyk;> Ke;ija tuyhW> fhy khWghLfs;> kUe;J
vLj;Jf;nfhz;ljw;fhd tuyhW kw;Wk; gof;f tof;fq;fs; Mfpatw;wpid
Nehahsp my;yJ ngw;Nwhuplk; Nfl;Lg;ngWjy;.
-mfj;jpaH
50
“ nka;f;Fwp epwe;njhdp tpopehtpUkyk; iff;Fwp”
5.4.1 ];guprk;
Njhy; twl;rp> nrhunrhug;Gf; fhZk;
5.4.2 eh
ghz;L Nehapy; eh ntSg;G> Ritapd;ik cz;lhFk;.
5.4.3 epwk;
cly;> fz; nts;tpop> eff;fz; ntSg;G cz;lhf;Fk;;.
5.4.4 nkhop
,ay;G
5.4.5 tpop
ghz;L Nehapy; fz; nts;tpop ntSj;jpUf;Fk;.
5.4.6 kyk;
kyf;fl;L> fopr;ry; Vw;gLk;.
5.4.7 %j;jpuk;( rpWePH)
ePh;f;Fwp
“ mUe;JkhwpujKk; mtpNuhjkjha;
m/fy; myHjy; mfhyT+d; jtpHe;jow;
Fw;wytUe;jp cwq;fp itfiw
Mbf;fyrj; jhtpNa fhJ nga;
njhU K$h;j;jf; fiyf; fl;gL ePupd;
epwf;Fwp nea;f;Fwp epUkpj;jy; flNd” (NjiuaH)
51
nea;f;Fwp
“ epwf;Fwpf; Fiuj;j epUkhz ePupw;
NjiuaH
“tpiuTld; fjpHNghy; ePz;L Ntw;Wikf; Fzq;fs; fz;lhy;
5.4.8 ehb
ehb eil
52
“nka;asT thjnkhd;W
Nky; gpj;Nkhuiuahk;
Iaq;fhnyd;Nw mwp”
-fz;Zrhkpak;
53
MODERN ASPECT - INTRODUCTION
1. PHYSIOLOGY
PROPERTIES OF BLOOD
1. COLOUR
Blood is red in color. Arterial blood is scarlet red because it contains more
oxygen and venous blood is purple red because of more carbon dioxide.
2. VOLUME
3. REACTION AND PH
5. VISCOSITY
Blood is five times more viscous than water. It is mainly due to red blood
cells and plasma.
54
COMPOSITION OF BLOOD
2. Formed elements, which are made up of the blood cells and platelets
The formed elements are so named because they are enclosed in a plasma
membrane and have a definite structure and shape. All formed elements are cells
except for the platelets, which are tiny fragments of bone marrow cells.
Blood plasma
Blood plasma is a mixture of proteins, enzymes, nutrients, wastes, hormones
and gases. The specific composition and function of its components are as
follows.
55
Proteins
These are the most abundant substance in plasma by weight and play a
part in a variety of roles including clotting, defense and transport. Collectively,
they serve several functions:
They are an important reserve supply of amino acids for cell nutrition. Cells
called macrophages in the liver, gut, spleen, lungs and lymphatic tissue can break
down plasma proteins so as to release their amino acids. These amino acids are
used by other cells to synthesis new products.
Plasma proteins also serve as carriers for other molecules. Many types of small
molecules bind to specific plasma proteins and are transported from the organs
that absorb these proteins to other tissues for utilization. The proteins also help
to keep the blood slightly basic at a stable pH. They do this by functioning as
weak bases themselves to bind excess H+ ions. By doing so, they remove excess
H+ from the blood which keeps it slightly basic.
The plasma proteins interact in specific ways to cause the blood to coagulate,
which is part of the body’s response to injury to the blood vessels (also known
as vascular injury), and helps protect against the loss of blood and invasion by
foreign microorganisms and viruses.
Plasma proteins govern the distribution of water between the blood and tissue
fluid by producing what is known as a colloid osmotic pressure.
FUNCTION OF BLOOD
1. NUTRITIVE FUNCTION
Nutritive substances like glucose, amino acid, lipids and vitamins
derived from digested food are absorbed from gastrointestinal tract and carried
by blood to different parts of the body for growth and production of energy.
56
2. RESPIRATORY FUNCTION
3. EXCRETORY FUNCTION
8. STORAGE FUNCTION
Water and some important substances like proteins, glucose, sodium
and potassium are constantly required by the tissues. Blood serves as a
readymade source for these substances. And, these substances are taken from
blood during the condition like starvation, fluid loss, electrolyte loss, etc.
57
9. DEFENSIVE MECHANISM
Blood plays an important role in the defense of the body. The white
blood cells are responsible for this function. Neutrophils and monocytes engulf
the bacteria by phagocytosis. Lymphocytes are involved in development of
immunity. Eosinophils are responsible for detoxification, disintegration and
removal of foreign proteins.
The plasma proteins play the major role in regulating the osmotic pressure of
tissue fluids.
Red blood cells are the non-nucleated formed elements in the blood. Red
blood cells are known as erythrocytes. Red color of the red blood cell is due to
the presence of the coloring pigment called hemoglobin. RBCs are more in
number compared to the other two blood cells, namely white blood cells and
platelets.
NORMAL SHAPE
Normally, the RBCs are disc shaped and biconcave (dumbbell shaped).
Central portion is thinner and periphery is thicker. The biconcave contour of
RBCs has some mechanical and functional advantages.
NORMAL SIZE
58
NORMAL STRUCTURE
RBC has a special type of cytoskeleton, which is made up of actin and spectrin.
PRODUCTION OF ERYTHROCYTES
5. After the age of 5 and adult – Red marrow of proximal end of long bones and
flat bones such as ribs, vertebrae, pelvis, sternum and iliac bone.
Sometimes under conditions of exchanged stimuli, reticulo endothelial
system also takes up the embryonic function and yellow marrow shall be
transformed into the red marrow. Even in these bones, the marrow becomes less
productive as age increase
60
61
The stage of maturation of the RBC are given below
Haemocytoblast
Reticulocyte Thyroxin
Protein
Erythrocyte Hormone
62
Stage 3- Intermediate Normoblast (Late erythroblast)
This cell is smaller (10- 15)µ and shows active mitosis. Haemoglobin
beings to appear and its eosinophilic staining give cytoplasm a polychromatic
appearance.
Mitosis has now ceased and the diameter of cell is 7- 10µ. The nucleus
is smaller and the condensed chromatin assumes a “cart wheel” appearance and
finally becomes deeply stained in a uniform manner. This appearance is called
pyknosis and is a stage in the degeneration of the nucleus, which breaks up and
finally disappears owing to the extrusion or lysis and a young RBC (reticulocyte)
is formed. The maximum level of haemoglobin is attained and the cytoplasm
gives eosinophilic reaction.
63
2. Transport of Carbon Dioxide from the tissues to the lungs
RBCs carry the blood group antigens like A antigen, B antigen and Rh
factor. This helps in determination of blood group and enables to prevent
reactions due to incompatible blood transfusion.
Average life span of red blood cell is about 120 days. Daily 10% of red
blood cells, which are senile, get destroyed in normal young healthy adults. This
causes release about 0.6% of haemoglobin into the plasma. From this 0.9 to
1.5mg% bilirubin is formed.
Adult
64
HEMOGLOBIN
AGE
SEX
FUNCTIONS OF HEMOGLOBIN
Buffer action
Hemoglobin acts as a buffer and plays an important role in acid- base balance.
65
STRUCTURE OF HEMOGLOBIN
Metabolisum of Haemoglobin:
I. Synthesis of haemoglobin
66
Catabolism of haemoglobin:
Erythrocytes at the end of their life span of 120 days are broken
down. Simultaneously the haemoglobin is degraded. Daily about 8gms of
haemoglobin are broken down in the body and this corresponds to the
formation of about 300mg of bile pigments per day. The normal sites
of haemoglobin degradation are the reticulo endothelial cells of the
spleen, bone marrow and liver. The globin which is the protein portion
may be reutilized as such or may break down further into its constituent
amino acids and enter to the amino acid "pool" for reutilization. The
haem portion breaks down resulting in the formation of bile pigments.
Destruction of Destruction of
senescents RBC’s maturing erythroeid
cells
Haemoglobin
12-50%
Haem + globin
Turnover of Haem
+
Haeam products
Haem oxygenase
Biliverdin
Biliverdin reductase
Adult : 45 + /- 10.0%
68
Mean Corpuscular Volume (M.C.V)
1-13 days : 98 fl
14-60 days : 90 fl
3 month-10years : 80 fl
11-15 years : 82 fl
Adult : 82 to 92 fl
3 month-10years : 27 picograms
Adult : 27 – 32 picograms
1-13 days : 36 – 34 %
14-60 days : 33 %
3 month- 10 years : 34 %
11-15 years : 34 %
Adult : 32 – 36 %
69
Reticulocytes
2 week : 1.0%
3 months : 1.0%
6months-6years : 1.0%
Adult : 1.6%
SYNTHESIS OF HEME
70
FORMATION OF GLOBIN
CONFIGURATION
Each polypeptide chain combines with one heme molecule. Thus, after
the complete configuration, each hemoglobin molecule contains 4 polypeptide
chains and 4 heme molecules.
Various materials are essential for the formation of hemoglobin in the RBC.
DESTRUCTION OF HEMOGLOBIN
71
3. PATHOLOGY OF ANEMIA
DEFINITION
2. Hemoglobin content
Grading of Anemia
Hb between 7 to 10 gm : Moderate
Hb under 7 gm : Sever
72
4. PATHOGENESIS - Etiology of Anemia
a. New born
1. Common causes
b. Infections
c. Nephritis, Nephrosis
d. Ankylostomiasis
a. Leukemia
In megaloblastic anemia large nucleated red blood cells are seen in the red
marrow of the bones. This immaturation is due to non- availability of Vitamin B
12, Folic acid.
The life span of matured red blood cells is about 120 days. Sometimes they
may die within their usual lifetime. This leads to anemia.
PATHOPHYSIOLOGY OF ANEMIA
Symptoms:
CLASSIFICATION OF ANEMIA
1. Morphological classification
2. Etiological classification
MORPHOLOGICAL CLASSIFICATION
75
2. Macrocytic Normochromic Anemia
RBCs are larger in size with normal color, RBC count is less. Folate and Vitamin
B12 deficiency, hypothyroidism.
RBCs are larger in size. MCHC is less, so the cells are pale Combined deficiency
of Iron and folate or Vitamin B12
4. Microcytic Hypochromic Anemia
Anemia
High Low
Reticulocyte Reticulocyte
Count Count
76
ETIOLOGICAL CLASSIFICATION
1. Hemorrhagic anemia
2. Hemolytic anemia
4. Aplastic anemia
The hemoglobin level at which symptoms of anemia appear, depends on the rate
of development of the anemia. Symptoms occur at higher hemoglobin levels if
anemia develops rapidly, as with hemorrhage.
The most common and earliest symptoms include lassitude, and easily
fatigability. Alternatively, children may have anorexia, irritability and poor
school performance.
The most prominent and characteristic sign is pallor, detected most reliably in
nail beds, oral mucous membranes and conjunctivae.
Observing palmar creases and skin is insufficient as the skin creases in children
lack pigmentation.
IRON
1. Iron mainly exerts its functions through the compounds in which it is present.
Hemoglobin and myoglobin are required for the transport of o2 and co2.
2. Cytochromes and certain non- heme proteins are necessary for electron transport
chain and oxidative phosphorylation.
3. Peroxidase, the lysosomal enzyme, is required for phagocytosis and killing of
bacteria by neutrophills.
4. Iron is associated with effective immunocompetence of the body.
78
Upto 10 years (M/F) - 10mg/day
IRON SOURCES
Rich sources
Muscle meat
Beef liver
Good sources
Greens
Leafy vegetables
Nuts
Cereals
Wheat germs
Fish
Shellfish
Poultry
Egg
Jaggery
Yeast
Molasses
Oysters
79
Poor sources
Wheat
Polished rice
Milk
IRON METABOLISM
1. Acidity, ascorbic acid, alcohol, fructose and cysteine promote iron absorption.
80
Iron in mucosal cells
The iron (Fe2+) entering the mucosal cells by absorption is oxidized to ferric
form (Fe3+) by the enzyme ferroxidase. Fe3+ then combines with apoferritin to
form ferritin which is the temporary storage form of iron. From the mucosal
cells, iron may enter the blood stream (which mainly depends on the body needs)
or lost when the cells are desquamated.
The ironliberated from the ferritin of mucosal cells enters the plasma in
ferrous state. Here, it is oxidized to ferric form by a copper-containing protein,
ceruloplasmin which possesses ferroxidase activity. Another cuproprotein
ferroxidase 2 also helps for the conversion of Fe2+ to Fe3+.
Storage of iron
Iron is stored in liver, spleen and bone marrow in the form of ferritin. In
the mucosal cells, ferritin is the temporary storage form of iron. A molecule of
apoferritin(mol.wt.500,000) can combine with 4,000 atoms of iron. The
maximum iron content of ferritin on weight basis is around 25%.
Hemosiderin
Hemosiderin is another iron storage protein which can hold about 35%
of iron by weight. Hemosiderin accumulates in the body(spleen, liver) when
the supply of iron is in excess of body demands.
81
are minimal which may occur through bile, sweat, hair loss etc. Iron is not
excreted into urine. Thus, iron
differs from the vitamins or other organic and inorganic substances which are
either inactivated or excreted during the course of metabolic function. Hence,
iron is appropriately regarded as a one-way substance.
Iron entry into the body is controlled at the absorption level, depending
on the body needs. Thus the periodical blood loss in menstruating women
increases its requirements. Increased iron demands are also observed in
pregnancy, lactation, and in growing children.
The iron released from the senescent, red cells during the first 8- 12 weeks
of life(a period of quiescent erythropoiesis) is stored in the body and helps to
maintain erythropoiesis upto 4-6 months in a normal term infant and upto 2-3
months in low birth weight infant. Normal infants at birth have about 75 mg of
iron per kg body weight, two thirds of which is present in red blood cells. Infants
and children should continue to absorb 0.8 to 1.0 mg of iron daily to reach the
adult body stores of 4-5 gms.
Normal body losses of iron are about 20µg/kg/day and most of these losses
82
occur by the shedding of cells from intestinal mucosa. These losses are small
and are relatively
constant but may increase many folds in the presence of diarrhea,
dysentery, and parasitic infections.
Certain factors protect infants from becoming iron deficient in first few
months of life. These includes
Preferential delivery of iron to the fetus during the pregnancy particularly during
last three months of gestation
Placental transform to the newborn immediately after birth when the cord is
allowed to pulsate before being clamped.
Exclusive breast feeding for first four to six months of life, due to better
bioavilability of iron from the breast milk.
The etiology varies with the age, sex and country of residence of the patient
Pregnancy
Preterms
Twins
83
3. Decreased iron assimilations
Iron malabsorption
Sprue
Pica
GITsurgery
Chronic diarrhea
Delayed weaning
Malnutrition
4. Blood loss
5. Increased demands
Prematurity
Iron malabsorption
Crohn‟s disease and ulcerativecolitis also are commonly associated with iron
deficiency.
Corticosteroids, Indomethacin and other non- steroidal anti-inflammatory
agents may also induce gastrointestinal tract bleeding.
Pathogenesis
86
TABLE - 02
Stage Manifestation
Haemoglobin(Hb) may still be normal but serum iron is low and TIBC
increased with a low serum ferritin and raised free erythrocyte
protoporphyrin(FEP)
3. Iron deficiency anemia
The flow of iron to erythoid marrow is impaired to cause reduction in
haemoglobin concentration with a progressive microcytic hypochromic anemia
associated with reduced serum iron, transferring saturation and serum ferritin
level.
Productive system
Mild pyrexia may occur with severe anemia but marked fever is due to either
the causative disorder or due to some complicating factor.
Signs
Koilonychia
Tachycardia
88
Smooth, pale, glossy palate
Systolic murmurs
Cardiomegaly
Symptoms
Weakness
Fatigue
Exercise intolerance
Loss of appetite
Irritability
Lack of concentration
Giddiness
Insomnia
Constipation
Breathlessness on exertion
Dimness of vision
Tinnitus
Anginal pain
Palpitation
Abdominal distension
89
Complication of iron deficiency anemia
In patients with heart disease severe anemia may precipitate angina pectoris or
congestive heart failure
Infections are more common in Iron deficiency anemia, especially those of
respiratory, gastrointestinal and urinary tracts.
1. Blood investigation
Differential count
Serum iron
Serum protein
Serum creatinine.
2. Urine investigation
Urine sugar
Albumin
Deposits
Red blood cells
Pus cells
90
3. Stool investigation
Occult blood
Organisms
Ova
Cyst
Pus cells
Isotope studies
Ultrasonography
DIFFERENTIAL DIAGNOSIS
1. Anemia of infection
4. Sideroblastic anemia
91
DIAGNOSIS
MANAGEMENT
PROPHYLAXIS
The main principles in the prevention of nutritional Iron deficiency anemia are,
PREVENTION OF IDEA
1. Protection and promotion of breast- feeding for as long as possible along with
timely weaning is effective in preventing IDA Low birth weight infants need
iron supplementation from the age of 2 months.
2. Dietary modification and consumption of larger amounts of habitual foods
increases total iron consumption by 25- 30 percent. Processes like germination,
consumption and green leafy vegetables would be additional long-term
methods for prevention of IDA.
3. Periodic deworming with anti-helminthic drugs for hookworm infestation and
schistosomiasis should be considered in endemic areas.
4. Supplementation with medicinal iron is considered necessary to reduce the
extent of anemia in developing countries.
5. Food and salt fortification with iron are evolving rapidly and would be one of
the most effective ways to control IDA. Salt fortification gives an iron content
of 1 mg per gram of salt in the preparation.
Poultry
93
Non-haem iron sources
Oatmeal
Nuts
Pulses
Dried fruit
Whole meat
Bread, eggs
2. Concentrate on green leafy vegetables, red meat, beef liver, poultry, fish,
wheat germ, oysters, dried fruit, and fortified cereals
3. Foods high in vitamin C like citrus fruits, tomatoes and strawberries help the
body absorbing iron from food
4. Red meat not only supplies a good amount of iron, it also increases
absorption of iron from other food sources
5. Take an iron supplement
8. Eat fresh uncooked fruits and vegetables often. Don‟t overcook food that
destroys folic acid.
94
EVALUATION OF DISSERTATION TOPICS
MATERIALS
The clinical study and Paandu was carrieded in the out patient in post graduate
department of Noinadal at Government Siddha Medical College and Hospital
Palayamkottai, Thirunelvely.
40 cases with clinical science and symptoms of Paandu both sex of all diferent
ages were studied under the guidance of faculties of post graduate department.
Selection of patients
The clinical study was done in cases, out of that 40 cases were selected on the
basis of clinical symptoms indicated in the Siddha text.
Selection criteria
Inclusion criteria
Age - 40 years to 65 years
Gender - Male and Female
Haemoglobin - below 10g/dl
Total RBC count - below 4.0 million/ mm3
PCV - below 30%
MCV - below 82 fl
MCH - below 27 pg
MCHC - below 32%
Peripheral smear - Result show anaemia
Patients who co-operate for investigation whenever necessary.
95
Exclution criteria
Age - below 39 years
Age – above 65 years
Investigation required
Blood
White Blood Count
Differential count
Red Blood Count
Haemoglobin
Pcak Cell Volume
Mean Corpuscular Volume
Mean corpuscular Hemoglobin
Mean Corpuscular Haemoglobin Concentration
Peripheral smear
Blood grouping
Erythrocyte Sedimentation Rate
Blood sugar
Blood urea
Serum Cholesterol
Urine
Albumin
Sugar
Deposites
Stool
Occult blood
96
METHODOLOGY
STUDY ENROLEMENT
In the study, patients reporting at the OPD and IPD of Government Siddha
Medical college and Hospital, Palayamkottai. With the clinical symptoms of
PAANDU will be referred to the research group. Those patients will be screened
using the screening proforma ( Form I) and examined clinically for enrolling in
the study based on the inclusion and exclusion criteria. Based on the inclusion
criteria the patients will be included first and excluded from the study on the same
day if they hit the exclution criteria.
The patient who are to be enrolled would be informed ( Form IV-A) about the
study, and the objectives of the study in the language and terms understandable
for them.
After ascertaining the patiet’s willingness, a written informed consent would be
obtaind from them in the consent form (Form IV)
All these patients will be given unique register card in which patients register
number of the study, Address, Phone number and Doctor phone number etc. will
be givn, so as to report to research group easily if any complication arises.
Compleete clinical history, complains and duration , examination finding all
would be recorded in the prescribed proforma in the history and clinical
assessment forms separately. Screening Form – I will be filled up , Form I-A,
Form II and Form III will be used recording the patient’s history, clinical
examination of symptoms and signs and lab investigations respectively.
LAB INVESTIGATION
Compleete blood test
Urine test
Blood Peripheral smears study
Blood group
97
TREATMENT DURING THE STUDY
Normal treatment procedure followed in Governtment Siddha Medical college
and Hospital, Palayamkottai will be prescripted to the study patient’s and the
treatment will be provide at free of cost.
STUDY PERIOD
TOTAL PERIOD
Total period - 24 months
Recruitment for the study - Upto 18 months
Data entry analysis - 4 months
Report preparation and submission - 2 months
DATA MANAGEMENT
After entrolling the patients in the study, a separate files for each patient will be
open and all forms will be filled in the files. Study No and patient No. Will be
entered top of file for the easy identification and arranged in a separate rack at the
concern OPD unit. whenever study patients visit OPD during the study period,
the respective patients file will be taken and necessary recording will be made at
the assessment form or other suitables form.
The screening forms will be seperatedely.
The Data recording will be monitored for completion and adverse event by Head
Of the Department and Faculty of the department. Any missed data found in
during the study, it will be collected form the patient, but the time related data not
be recorded retrospectively.
All collected data will be analysed using SPSS V 2.0
STATISTICAL ANALYSIS
Data on sign and symptoms, complete blood count ( Hb, WBC, DC, PCV,
MCV, MCH, MCHC) and peripheral smear and other diagnostic stool will be
analysed by using SPSS V 2.0 version.
98
OUTCOME OF STUDY
According to the references of the text books the diagnostic outcome of the
study includes validation of Siddha diagnostic tools such asNeerkuri, Neikuri,
Envagai thervugal and Manikkadai nool in Paandu with good results.
ETHICAL ISSUES
To prevent any infection, while collecting blood samples from the patients, only
disposable syringes, disposable gloves , with proper sterilization of lab
equipments will be used.
The data collected from the patient will be kept confidentially. The patient will be
informed about the diagnosis.
After the consent of the patients (through written consent form) they will be
entrolled in the study.
Informed consent will be obtained from the patients explaining in the
understandable language to the patient.
This study involves only the necessary investigations.
No other unwanted investigation would be done.
Normal treatment procedure followed in GSMC and Hospital will be prescribed
to the study patents.
There will be no infrigement on the rights of patient.
1. Age distribution
2. sex
3. Religion
4. Diet habbits
5. Educational status
6. Food
7. Udal thathukkal
8. General etiology
99
9. General clinical Sign and symtoms
10. Iymporikal
11. Kanmainthiriyankal
12. Gunam
13. Kosam
14. Uyirththathukkal
I. Vali
II. Azhal
III. Iyam
15. Types of Paandu
16. Noi uttra kaalam
17. Noi utra nilam
18. Envagaithervugal
I. Naa-Suvai, Niram
II. Mozhi
III. Vizhi
IV. Isparism
V. Malam
VI. Mooththiram – Neerkkuri, Neikkuri
VII. Naadi – Kaalam, Naadi nadai
19. Manikkadai nool
20. Blood grouping
21. Phripheral smear
100
OBSERVATIONS AND RESULTS
3 51- 55 7 17.50%
4 56-60 13 32.50%
5 61-65 7 17.50%
14 13
12
10
8
NO OF CASES
8 7 7
6 5
2
20.00% 12.50% 17.50% 32.50% 17.50%
0
40 - 45 46 - 50 51- 55 56-60 61-65
AGE DISTRIBUTION
NO OF CASES PERCENTAGE
101
TABLE 04 : SEX
SEX NO OF
S.NO DISTRIBUTION CASES PERCENTAGE
1 Male 16 40%
2 Female 24 60%
Sex
25
20
15
NO OF CASES
NO OF CASES
PERCENTAGE
10
0
Male Female
SEX
102
TABLE 05 : RELIGION
RELIGION NO OF
S.NO DISTRIBUTION CASES PERCENTAGE
1 Hindu 33 82.50%
2 Christian 6 15.00%
3 Muslim 1 2.50%
40
RELIGION
35 NO OF CASES PERCENTAGE
30
25
20
15
10
0
Hindu Christian Muslim
103
TABLE -06 DIET HABBIT
DIET NO OF
S.NO DISTRIBUTION CASES PERCENTAGE
1 Tea 28 70%
2 Coffe 19 47.50%
3 Smoking 6 15%
4 Alcohol 1 2.50%
5 Betelnut 19 47.50%
6 Yoga 1 2.50%
7 Tobbcco 4 10%
DIET HABBIT
30 28
25
20 19 19
15
10
5 4
70% 1 1
47.50% 15% 2.50% 47.50% 2.50% 10%
0
Tea Coffe Smoking Alcohol Betelnut Yoha Tobbcco
NO OF CASES PERCENTAGE
104
TABLE 07 EDUCATIONAL STATUS
EDUCATION NO OF
S.NO DISTRIBUTION CASES PERCENTAGE
1 Illiterate 9 22.50%
2 Literate 24 60.00%
3 Student 0 0.00%
4 Graduate 7 17.50%
EDUCATION STATUS
7
9
Illiterate
Literate
Student
Graduate
24
TABLE 08 FOOD
FOOD NO OF
S.NO DISTRIBUTION CASES PERCENTAGE
1 Vegetable 7 17.50%
FOOD DISTRIBUTION
Vegetable Mixed Diet
33
82.50%
17.50%
7
NO OF CASES PERCENTAGE
105
TABLE 09 UDAL THATHUKKAL
UDAL NO OF
S.NO THATHUKKAL CASES PERCENTAGE
1 Saram 40 100%
2 Senner 40 100%
3 Oon 15 37.5%
4 Kozluppu 15 37.5%
5 Enbu 10 25%
6 Moolai 00 00%
7 Sukkilam/Suronitham 40 00%
UDAL THATHUKKAL
40
35
30
25
20
15
10
5
0
NO OF CASES PERCENTAGE
106
TABLE 10- GENERAL ETIOLOGY
NO OF
S.NO GENERAL ETIOLOGY CASES PERCENTAGE
1 Poor nutritional Diet 40 100%
3 Alcoholism 1 2.5%
5 Medication 0 0
6 Malignancy 0 0
40 0
GENERAL ETIOLOGY
107
TABLE 11- GENERAL CLINICAL SYMPTOMS
GENERAL CLINICAL NO OF
S.NO SYMPTOMS CASES PERCENTAGE
1 Stomatities 13 32.5%
7 Anorexia 32 80.0%
8 Palpitation 28 70.0%
9 Lassitute 38 95.0%
10 Tiredness 38 95.0%
11 Bradycardia 0 000%
15 Murmur 0 000%
NO OF CASES PERCENTAG
40
35
30
25
20
15
10
108
TABLE 12- IYMPORIKAL
NO OF
S.NO IYMPORIKAL CASES PERCENTAGE
1 Mei 30 75%
2 Vaai 22 55%
3 Kan 30 75%
4 Mooku 00 00
5 Sevi 00 00
IYMPORIKAL
30
25
20
15
10
0
Mei Vaai Kan Mooku Sevi
NO OF CASES PERCENTAGE
109
TABLE -13 KANMETHIRIYANGAL
NO OF
S.NO KANMENTHIRIYANKAL CASES PERCENTAGE
1 Kai 20 50%
2 Kaal 20 50%
3 Vaai 22 55%
4 Eruvaai 30 75%
5 Karuvaai 0 0
KANMENTHIRIYANKAL
NO OF CASES PERCENTAGE
30
25
20
15
10
0
Kai Kaal Vaai Eruvaai Karuvaai
110
TABLE 14 - GUNAM
NO OF
S.NO GUNAM CASES PERCENTAGE
1 Saththuvam 0 0
2 Rasatham 08 20%
3 Thamasam 32 80%
GUNAM
35
30
25
20
15
10
0
Saththuvam Rasatham Thamasam
NO OF CASES PERCENTAGE
111
TABLE – 15 KOSAM
NO OF
S.NO KOSAM CASES PERCENTAGE
1 Annamaya Kosam 40 100%
2 Pranamaya Kosam 30 75%
3 Manomaya Kosam 0 00
4 Vinganamaya Kosam 0 00
5 Ananthamaya Kosam 0 00
KOSAM
40
35
NO OF CASES PERCENTAGE
30
25
20
15
10
0
Annamaya Kosam Pranamaya Manomaya Kosam Vinganamaya Ananthamaya
Kosam Kosam Kosam
112
TABLE -16 UYIRTHATHUKKAL
NO OF
S.NO VALI CASES PERCENTAGE
1 Pranan 30 75%
2 Abanan 30 75%
3 Samanan 40 100%
4 Udanan 35 87.50%
5 Viyanan 30 75%
6 Naagan 5 12.50%
7 Koorman 5 12.50%
8 kirukaran 35 87.50%
9 Thevathaththan 35 87.50%
10 Thananjeyan
UYIRTHATHU - VALI
40
NO OF CASES PERCENTAGE
35
30
25
20
15
10
113
TABLE – 17 AZHAL
NO OF
S.NO AZHAL CASES PERCENTAGE
1 Anila piththam 40 100%
5 Saathaka piththam 0 00
AZHAL
40
NO OF CASES PERCENTAGE
35
30
25
20
15
10
0
Anila Ranjaka Prasaka Aalosaka Saathaka
piththam piththam piththam piththam piththam
114
TABLE – 18 IYAM
2 Kilethagam 40 100%
3 Pothagam 15 37.50%
4 Tharppagam 5 12.50%
5 Santhigam 20 50%
NO OF CASES PERCENTAGE
40
35
30
25
20
15
10
0
Avalambagam Kilethagam Pothagam Tharppagam Santhigam
115
TABLE – 19 TYPE OF PAANDU
S.NO TYPES OF PAANDU NO OF CASES PERCENTAGE
1 Vathapaandu 5 12.50%
2 Piththapaandu 32 80%
3 Kapapaandu 3 7.50%
4 Vishapaandu 0 0
5 Miruthikapaandu 0 0
TYPE OF PAANDU
35
NO OF CASES
PERCENTAGE
30
25
20
15
10
0
Vathapaandu Piththapaandu Kapapaandu Vishapaandu Miruthikapaandu
116
TABLE – 20 NOI UTTRA KAALAM
S.NO NOI UTTRA KAALAM NO OF CASES PERCENTAGE
1 Kaarkaalam 1 2.50%
2 Koothirkaalam 5 12.50%
3 Munpanikkaalam 25 62.50%
4 pinpanikkaalam 9 22.50%
5 Illavenirkaalam 0 0
6 Mudthuvenirkaalam 0 0
20 NO OF CASES PERCENTAGE
15
10
117
TABLE – 21 NOI UTTA NILAM
S.NO NOI UTTRA NILAM NO OF CASES PERCENTAGE
1 Kurinji 3 7.5%
2 Mullai 24 60%
3 Marudham 8 20%
4 Neidhal 5 12.5
5 Paalai 0 0
20
15
10
0
Kurinji Mullai Marudham Neidhal Paalai
NO OF CASES PERCENTAGE
118
TABLE – 22 ENVAGAI THERVUGAL
S.NO NAAKKU - SUVAI NO OF CASES PERCENTAGE
1 Inippu 0
2 Uppu 3 7.50%
3 Kaarppu 0
4 Pulippu 5 12.50%
5 Kaippu 32 80%
6 Thuvarppu 0
NAA- SUVAI
NO OF CASES
PERCENTAGE
35
30
25
20
15
10
0
Inippu Uppu Kaarppu Pulippu Kaippu Thuvarppu
119
TABLE – 23 NAA NIRAM
S.NO NIRAM NO OF CASES PERCENTAGE
1 Karuppu 3 7.50%
2 Manjal 4 10%
3 Veluppu 33 82.50%
NIRAM
Karuppu
Manjal
Veluppu
120
TABLE – 24 MOZHI
S.NO MOZHI NO OF CASES PERCENTAGE
1 Sama oli 9 22.50%
MOZHI
NO OF CASES
PERCENTAGE
30
20
10
0
Sama oli Uraththa oli Thaazhntha oli
TABLE – 25 VIZHI
S.NO VIZHI NO OF CASES PERCENTAGE
1 Manjal 6 15%
2 Veluppu 33 82.50%
3 Sivappu 1 2.50%
Manjal
Veluppu
Sivappu
Veluppu
82.5%
121
TABLE – 26 ISPARISAM
NO OF
S.NO ISPARISAM CASES PERCENTAGE
1 Veppam 16 40%
2 Midhaveppam 24 60%
3 Thatpam 0
1 Viyarvai 2 5%
1 Thoduvali 3 7.50%
ISPARISAM
NO OF CASES
25
PERCENTAGE
20
15
10
0
Veppam Midhaveppam Thatpam Viyarvai Thoduvali
122
TABLE – 27 MALAM - THANMAI
S.NO MALAM - THANMAI NO OF CASES PERCENTAGE
1 Karuppu 0 0
2 Manjal 40 100%
3 Velluppu 0 0
1 Ilakal 0 0
2 Irukal 32 80%
3 Thin 6 15%
4 Bulgy 2 5%
40
35
30
25
20
15
10
0
Karuppu Manjal Velluppu Ilakal Irukal Thin Bulgy
123
TABLE – 28 MOOTHTHIRAM - NEIKKURI
MOOTHTHIRAM -
S.NO NEERKKURI NO OF CASES PERCENTAGE
1 Venmai 0 0
2 Sivappu 1 2.50%
3 Manjal 39 97.50%
1 Manam 5 12.5%
2 Nurai 5 12.50%
3 Edai 0 0%
4 Enjal 2 5%
MOOTHTHIRAM - NEERKKURI
40
35
30
25
20
15
10
0
Venmai Sivappu Manjal Manam Nurai Edai Enjal
124
TABLE – 29 MOOTHTHIRAM - NEIKKURI
MOOTHTHIRAM - NO OF
S.NO NEIRKKURI CASES PERCENTAGE
1 Arvam 3 7.50%
2 Mothiram 4 10%
3 Muththu 2 5%
5 Aravil muththu 0 0
8 Muththil Aravam 2 5%
9 Muththil mothiram 0
18
16
14
12
10
125
TABLE – 30 NAADI - KAALAM
NAADI - NO OF
S.NO KAALAM CASES PERCENTAGE
1 Kaarkaalam 2 5%
2 Koothirkaalam 2 5%
3 Munpanikkaalam 18 45%
4 Pinpanikkaalam 13 32.50%
5 Ilavenitkaalam 4 10%
6 Mudhuvenitkaalam 1 2.50%
NAADI - KAALAM
126
TABLE – 31 NAADI – NAADI NADAI
NAADI - NADI NO OF
S.NO NADAI CASES PERCENTAGE
1 Vali 0 00%
2 Azhal 0 00%
3 Iyam 0 00%
4 Valiazhal 12 30%
5 Valiaiyam 0 00%
6 Azhalvali 23 57.50%
7 Azhalaiyam 4 10%
8 Iyavali 1 2.50%
9 Iyaazhal 0 00%
10 Sanni 0 00%
25
20
15
NO OF CASES
10 PERCENTAGE
127
TABLE – 32 MANIKKADI NOOL
1 71/4 2 8
2 7 1/2 0 1
3 8 0 1
4 8 1/4 0 1
5 8 1/2 2 4
6 8 3/4 3 2
7 9 1 2
8 9 1/4 3 2
9 9 1/2 4 2
10 9 3/4 1 1
Chart Title
10
0
1 2 3 4 5 6 7 8 9 10
128
TABLE – 33 TABLE BLOOD GROUPING
Rh Rh
A/ A Positi negati
A1 B O B ve ve
VATHA
PAANDU 2 2 0 1 5
PITHTHA 1
PAANDU 4 6 7 5 31 1
KAPA
PAANDU 1 0 2 0 3
35
30
25
A/A1
20 B
O
AB
15 Rh Positive
Rh negative
10
0
VATHA PAANDU PITHTHA PAANDU KAPA PAANDU
129
TABLE – 34 PERIPHERAL SMEAR
Piththam
Vatham
P Percentage
ePercentage
Percentage
TOTAL Total
Kapam
ANAEMIA
TYPES ( case) P PERCENTAGE
IRON
DEFICIENCY 2 5% 14 35% 1 2.50% 17 42.50%
HYPOCHROMIC
MICROCYTIC 3 7.50% 15 37.50% 1 2.50% 19 47.50%
PERIPHERAL SMEAR
16
14
12
Vatham
10 Percentage
Piththam
8 Percentage
Kapam
6 Percentage
TOTAL
4 Total PERCENTAGE
0
IRON DEFICIENCY HYPOCHROMIC OTHERS
MICROCYTIC
130
131
132
133
134
135
136
TABLE – 35 ENVAGAI THERVUGAL AND MANIKKADAI NOOL
ISPARISAM
MOZHI
NIRAM
VIZHI
AG SE NEERKUR MANIKKAD
S.NO
MP/VL/UP/V
4 35402 48 F D VL TO VL MD MN/BL MN MUA IK/VP/ML/VI/VA LF 9
MP/VP/ML/VI/A
5 9319 60 M MN/KI VL SO VL VP MN/IR MN MOMU V RT 8 3 /4
MN/IR/D PP/VP/ML/VI/A
9 11134 40 F MN/KI/VD VL UO MN MD E MN MO V LF 9 1/2
137
ISPARISAM
MOZHI
NIRAM
VIZHI
AG SE NEERKUR MANIKKAD
S.NO
OP.NO NAA MALAM NEIKURI NAADI
E X I AI
MP/VP/ML/VI/A
13 11615 60 F MN/KI VL UO VL VP MN/IR MN MOMU V LF 7 1/4
14 11616 63 M VP/MN VL SO VL VP MN/IR MN MOA MP/VP/IY/VI/VA RT 9 1/4
MP/VP/ML/VI/A
15 11617 52 F MN/KI VL UO MN VP MN/IR MN MOMU V LF 8 3/4
16 11618 61 M MN/KI VL SO VL MP MN/IR MN MOA MP/VP/IY/VI/AV RT 9 12
MP/VL/KI/V PP/VP/ML/VI/A
18 13511 60 M D VL UO VL MP/TV MN/IR MN MUA V RT 9 1/2
PP/VP/ML/MI/A
19 14850 58 F MN/KI VL SO VL MP MN/IR MN MO V LF 7 1/4
20 14851 52 F MN/KI VL TO VL MP MN/IR MN MOA PP/VP/IY/MI/VA LF 8 3/4
PP/VP/VV/MN/A
24 16114 45 F MN/KI/VD MN TO MN VP MN/IR MN MOMU V LT 9
138
ISPARISAM
MOZHI
NIRAM
VIZHI
AG SE NEERKUR MANIKKAD
S.NO
OP.NO NAA MALAM NEIKURI NAADI
E X I AI
PP/VP/ML/MN/A
25 16115 60 F VL/KI/VD MN UO MN VP MN/IR MN MOMU V LT 9 1/4
PP/VP/ML/VI/A
26 16586 60 M MP/VL/KI VL SO VL MD MN/IR MN MOMU V RT 7 1/4
PP/VP/ML/VI/V
27 16589 60 M VL/KI VL UO VL VP MN/IR MN MOA A RT 8 3 /4
MD/T
29 16592 45 M VL/PU/VNU KA UO VL V MN/TN MN MOA PP/VP/IY/VI/VA RT 9 1/4
MD/V PP/VP/VV/MN/A
31 18601 40 F MN/UP/VD VL TO VL Y MN/BL MN MU V LT 9 1/2
PP/VP/IY/MN/V
32 18967 58 M KA/PU/VD KA SO VL MD MN/TN MN AMO A RT 8 1/2
MOMU PP/VP/VV/MN/A
33 21052 55 F MN/KI/VD VL TO VL VP/TV VL/IR MN/EN PP/VP V LT 7 1/4
MP/VL/KI/V
35 21178 48 F D VL UO VL MD MN/TN MN MOA PP/VP/IY/VI/IV LT 8 1/2
139
ISPARISAM
MOZHI
NIRAM
VIZHI
AG SE NEERKUR MANIKKAD
S.NO
OP.NO NAA MALAM NEIKURI NAADI
E X I AI
PP/VP/ML/VI/V
36 21290 52 M MN/KI VL UO VL MD MN/IR MN MOA A RT 9 1/2
37 21291 58 F VP/KI VL SO VL MD MN/IR MN MOMU PP/VP/IY/VI/AV LF 7 1/2
PP/VP/ML/VI/A
40 32057 40 F VP/KI VL UO VL MD MN/IR MN/NU MOMU V LT 8 1/4
M – Male F – FEMALE KP- KARUPPU MN- MANJAL VL – VELUPPU O- OTHERS IR- IRUKAL
140
AI – AZHALIYAM IV – IYAVALI IA – IYAAZHAL SA – SAMAOLI UO – URATHTHA OLI
MO- MOTHIRAM MU- MUTHTHU AMO- ARAVIL MOTHIEAM AMU – ARAVIL MUTHTHU
141
TABLE – 36
BLOOD URINE
P. SMEAR
RBC HB PCV MCV MCH MCHC TC N L E ESR SUGAR UREA S.CHOLES ALBUM SUGA DEPO
S.NO
OPD
GROUP
m/mm3 g/dl % fl pg gdl cls/mm3 % % % mm/hr mg/dl mg/dl mg/dl ce
1 32819 3.59 9.9 25.8 87.5 27.6 31.5 5900 83 13 1 40 NMA B 104 R 30 198 NIL NIL NAD
2 34932 2.8 8.6 25.8 87.7 26.5 34.2 7700 74 20 4 26 HMA A 90 F 12 196 TRACE NIL 10 pu
3 35206 2.9 8.9 26.7 82.4 26.5 32.9 6900 66 30 3 16 HMA O 120 R 10 198 NIL NIL NAD
FUL
4 35402 2.95 91 27.2 80.9 24.3 32.3 7900 59 9 2 64 IDA O 76 R 30 186 TRACE NIL
PUS
5 9319 3 9.2 27.8 87.5 26.3 33 5900 50 49 1 4 HMA A 99 F 18 135 NIL NIL NAD
6 9321 2.95 9 26.8 83.5 27.6 33.8 8100 69 27 4 20 HMA B 76 F 65 183 FEW NIL 18 P
7 9750 2.66 8 24 78.4 23.2 33.7 6000 57 7 6 135 SIDA B 128 R 60 162 NIL NIL FEW
8 9751 3.3 10 29.8 74.5 25.4 33.2 6500 68 28 4 81 IDA B 522 R 25 180 FEW B.RED 15 P
9 11134 2.2 6.6 19.8 70.1 22.4 31.7 8100 63 33 4 20 HMA A 96 F 28 190 NIL NIL NAD
10 11439 2.7 8 24.8 83.5 27.4 33.5 8400 73 23 4 10 HMA B 93 F 30 160 NIL NIL NAD
11 11440 3.32 10 30.4 90.3 28.4 34.7 8800 70 20 10 68 DMPA O 114 R 18 162 TRACE NIL 10PU
12 11442 2.9 8.7 26.1 88.2 28.1 33.9 6900 67 28 5 33 HMA AB 84F 26 158 NIL NIL FEW
13 11615 2.96 8.9 26.7 85.8 27.6 33.2 10500 85 13 2 15 IDA AB 85 F 20 140 NIL NIL NAD
142
BLOOD URINE
P. SMEAR
SUGAR UREA S.CHOLES ALBUM SUGA DEPO
S.NO
OPD
GROUP
m/mm3 g/dl % fl pg gdl cls/mm3 % % % mm/hr mg/dl mg/dl mg/dl ce
14 11616 3.31 10 30.2 87.5 28.6 33.8 6100 65 31 4 16 HMA O 187 R 18 220 NIL NIL NAD
15 11617 3.53 10 31.8 82.3 27.5 32.4 6100 67 30 3 92 HMA A 7O R 30 224 TRACE NIL CAL
16 11618 3.2 9.6 28.8 89.5 28.1 33.6 7500 63 34 3 20 DMPA B 102 R 25 152 NIL NIL NAD
17 13510 3.2 9.8 29.4 82.4 25.5 32.1 7500 60 36 4 30 HMA B 68 R 28 168 NIL NIL NAD
18 13511 3.1 9.3 27.9 83.2 28.1 34.5 8400 65 33 2 10 IDA B 92 R 32 182 NIL NIL NAD
19 14850 2.86 8.6 25.8 82.3 25.4 32.8 9400 69 25 5 50 IDA B 147R 18 196 NIL NIL 3 PU
20 14851 3.35 10 30.3 86.4 28.1 34.2 6300 58 40 2 50 HMA B 270 F 58 240 NIL B.RED NAD
21 14852 3.35 8 30.3 76.4 22.7 34.6 7300 70 24 6 19 SIDA B 73 R 22 196 NIL NIL NAD
22 15165 2.5 7.6 22.8 89.4 27.6 33.3 9500 79 18 3 128 HMA AB 74 F 78 145 TRACE NIL 5 PU
23 15166 2.95 9 26.8 85.4 25.9 32.1 8700 75 22 3 55 HMA 0 121 R 32 128 NIL NIL 2 PU
24 16114 3.2 9.9 29.7 79.4 26.2 33.3 5900 53 43 4 32 IDA AB 83 F 20 215 NIL NIL NAD
25 16115 3.3 10 29.7 72.3 21.4 30.5 5100 70 27 3 70 SIDA O 140 R 32 204 NIL NIL NAD
26 16586 3.3 9.9 29.7 80.1 24.3 34.5 6600 68 30 2 20 SIDA B 79 F 22 171 NIL NIL FEW
27 16589 2.8 8.4 25.2 73.5 24.7 34.1 10500 70 20 10 90 IDA O 111 R 18 203 NIL P 5 PU
28 16590 3.1 9.3 27.9 89.3 26.6 34.1 5300 53 40 7 60 HMA B 144 R 30 140 TRACE NIL FEW
29 16592 3.33 10 30.1 78.9 22.3 33.9 8800 67 27 6 125 IDA A 75 R 18 162 POSITV NIL FEW
143
BLOOD URINE
P. SMEAR
SUGAR UREA S.CHOLES ALBUM SUGA DEPO
S.NO
OPD
GROUP
m/mm3 g/dl % fl pg gdl cls/mm3 % % % mm/hr mg/dl mg/dl mg/dl ce
30 16635 2.83 8.4 25.2 78.6 23.5 30.9 8100 73 20 7 70 IDA B 111 R 34 207 NIL NIL NAD
31 18601 2.83 8.5 25.2 89.2 27.8 33.4 6500 61 28 2 20 DMPA A1 105 R 12.5 175 NIL NIL NAD
32 18967 3.26 9.8 29.4 87.5 26.3 33 9900 69 30 1 60 HMA A 87 R 37 179 NIL NIL FEW
33 21052 2.95 9 26.5 82.3 24.8 33.7 6600 57 40 3 45 IDA O 160 F 22 223 NIL NIL 3 PU
34 21151 2.7 9.4 24.8 83.5 27.4 33.5 9000 69 22 9 40 HMA B 140 R 23 171 NIL NIL NAD
35 21178 2.8 8.6 25.8 88.5 29.4 34.5 8300 70 23 7 110 HMA AB 80 F 48 182 NIL NIL NAD
36 21290 3.36 10 30.4 87.2 28.7 32.8 9200 60 31 9 30 HMA AB 70 R 48 170 NIL NIL NAD
37 21291 3.23 9.7 29.1 80 23.5 31.2 6600 60 37 3 28 IDB12F O 117 R 28 241 NIL NIL FEW
38 21294 3.26 9.8 29.4 83.2 26.5 33.3 7400 67 30 3 140 IDA B 314 R 28 152 NIL B.RED FEW
39 21295 3.16 9.5 28.5 77.4 23.5 32.9 10400 50 32 18 80 SIDA B 200 R 38 240 TRACE YELLOW 10 P
40 32057 3.26 8.2 29.4 83.2 26.5 33.3 7800 68 29 2 90 IDA B 138 R 20 224 NIL NIL NAD
144
DISCUSSION
40 Cases of Paandu noi have taken for clinical study in the Noinadal Post-
graduate Out Patient Department of Government Siddha Medical College and
Hospital, Palayamkottai. In this study by author analysed the clinical features,
depicted in the poem “Agasthiyar gunavaakadam” about PAANDU NOI.
TABLE – 37
145
Bitter in taste 32 Excessive 02
sweating
Emaciation 26 Chillness of Absent
eyes
Thoracic pain 01
Anasarca Absent
Chest pain Absent
Out of 40 cases, pain in the extremities and abdomen , Oedema of eyes, face and
arm , Pallor of the body ,Vomiting, Hic cough and Excessive salivation are present
special sign and symptoms of the Vathappaandu. These symptoms are not present
in other types of Paandu. By author consider this type of paandu noi is
Vaathapaandu.
Out of 40 cases, Yellowish colouration of the body, eyes, nail and urine, Mood
swing, loss of intelligence, Memory loss, Tiredness, Body itching, Bitter in taste
and Emaciation are present special sign and symptoms of the Piththapaandu.
These symptoms are not present in other types of Paandu. By author consider this
type of paandu noi is Piththapaandu.
Out of 40 cases, Shining of the skin, Oedema of feet and dorsum of the hand,
Abdominal swelling, Huskey voice, Excessive sweating and Thoracic pain are
present special sign and symptoms of the Kaphapaandu. These symptoms are not
present in other types of Paandu. By author consider this type of paandu noi is
Kaphapaandu.
2. Envagai thervukal
2.7.1 Neerkuri
– Saaram and Senner are affected in 100 % of cases. By Author considering this
result is indicate the Paandu noi.
149
4. UYIRTHTHATHUKKAL : Out of 40 cases
4.1 Vali
4.2 Azhal
150
4.3 Iyam
5. MUKKUTTA VERUPAADU
6. MANIKKADAI NOOL
71/4 Viratkadai is present in 25% of cases
71/2 Viratkadai is present in 2.5% of cases
8 Viratkadai is present in 2.5% of cases
81/4 Viratkadai is present in 2.5% of cases
81/2 Viratkadai is present in 15% of cases
83/4 Viratkadai is present in 12.5% of cases
9 Viratkadai is present in 7.5% of cases
91/4 Viratkadai is present in 12.5% of cases
91/2 Viratkadai is present in 15% of cases
151
93/4 Viratkadai is present in 5% of cases
According to the Siddha text is described 71/4 Viratkadai indicate the Hip
pain, Pain, Stiffness, eye ache, PAANDU, SOKAI, Burning sensation of the hand
and leg , Excessive sleep. By Author considering 25% of cases have 7 1/4
viratkadai in the Paandu noi.
8. BLOOD GROUPING –
Out of 40 cases
32 piththa (80%) cases is contain 40% of cases in B blood group, 17.5% of cases
in O blood group, 12.5% of cases in AB blood group and 10% of cases A/A1
blood group.
5 Vatha cases (12.5%) is contain 5% of cases in B blood group, 5% of cases in
A blood group and 2.5% of cases in AB blood group
3 Kapa cases (7.5%) is contain 5% of cases in O blood group and 2.5% of cases
in A1 blood group.
152
Out of 40 cases
97.5% of cases Rh positive
2.5% of case Rh negative
153
SUMMARY
Various aspects of examination including Mukkuttam, Udal Thathukkal,
Envagai thervugal are done recorded as proof.
Maximum number of cases are recorded with Poor nutritional Diet and
Alteration on cooking food habits which may be major causative factor for the
disease of Paandu
Interpretation of Sign and Symptoms
100% cases depicted the major signs and symptoms as mention in the
poem “PAANDU” in the text book “Agasthiyar Gunavaakadam” Among 40
cases
Interpretation of Age
Paandu prominently found to occur in the age between 56- 60 years are affected
in 32.5% of cases
40 to 45 years of age are affected in 20% of cases
51 to 55 years and 61 to 65 years of age are affected in 17.5% of cases
154
46 to 50 years of age are affected in 12.5% of cases .
Interpretation of Sex
Out of 40 cases Paandu prominently found to occur in 60% of female cases are
affected.
Out of 40 cases 40% of male cases are affected.
Interpretation of Religion
Out of 40 cases Paandu noi mostly affected 82.5% of cases in Hindu religion
Out of 40 cases Paandu noi affected 15% of cases in Christian religion
Out of 40 cases Paandu noi affected 2.5% of cases in Muslim religion
Interpretation of Iymporikal
Out of 40 cases, mostly affected 75% of cases in mei and kan
155
Out of 40 cases, affected 55% of cases in Vaai
Interpretation of Kanmainthiriyankal
Out of 40 cases, mostly affected 75% of cases in eruvaai
Out of 40 cases, affected 55% of cases in vaai
Out of 40 cases, affected 55% of cases in kai and kaal
Interpretation of Gunam
Out of 40 cases, mostly prominent in 80% of cases in Thamasam
Out of 40 cases, prominent in 20% of cases in Rasatham.
Interpretation of Kosam
Out of 40 cases, prominently found in 100% of cases in Annamaya Kosam
Out of 40 cases, found in 75% of cases in Piranamaya kosam
Interpretation of Uyirthathukkal –
Out of 40 cases in vali ,
Samanan is affected in 100% of cases
Uthanan is affected in 87.5% of cases
Kirukaran is affected in 87.5% of cases
Thevathaththan is affected in 87.5% of cases
Pranan, Abanan and Viyanan are affected in 75% of cases
Nagan and Koorman are affected in 12.5% of cases
156
Thatpagam is affected in 12.5% of cases
Interpretation of Noi utta Kalam (seasonal variation) - Out of the 40% Paandu
Paandu prominently found to occur in 62.5% of cases are affect in
Munpanikkalam
22.5% of cases are affected in pinpanikkalam
12.5% of cases are affected in Koothikalam
2.5% of cases are affected in Kaarkaalam
157
Pallorness due to impaired Ranjaka Piththam
Suppression of taste due to Kabha constitution
Interpritation of NIRAM
Pallorness (velluppu) of the skin noted in 82.5% of cases
Yelow colouration of the skin noted 10% of cases
Black colouration of the skin is noted 7.5% of cases
Interpretation of Mozhi
60% of cases are with Uraththa oli
22.5% of cases are with Sama oli
17.5% of cases are with Thaazhntha oli
Interpretation of Vizhi
Pallorness of conjunctiva noted in 82.5 % of cases
Yellow colouration of conjunctiva noted in 15 % of cases
Red colouration of conjunctiva noted in 2.5 % of cases
Interpretation of Isparism
60% of cases are Midha veppam in nature
40% of cases are veppam in nature
7.5% of cases are affected in Thoduvali
5% of cases are affected in Increased Viyarvai
Interpretation of Malam
Yellow colouration of the malam is noted 100% of cases
Irukal present in 80% of cases
Bulky of stool is noted in 5% of cases
158
Interpretation of Mooththiram
Neerkkuri
Yellow colouration of urine is present in 97.5% of cases
Red colouration of urine is present in 2.5% of cases.
Nurai is present in 12. 5% of cases
Manam is present in 12. 5% of cases
Enjal is present in 5% of cases
Neikkuri
Mothiraththil Muththu shape is present in 42.5% of cases
Mothiraththil Aravam shape is present in 27.5% of cases
Mothiram shape is present in 10 % of cases
Aravam shape is present in 7.5% of cases
Muththu shape is present in 5% of cases
Muththil Aravam shape is present in 5% of cases
Aravi Mothiram shape is present in 2.5% of cases
Interpretation of Naadi
Kaalam
45% of cases naadi are present in munpani kaalam
32.5% of cases naadi are present in pinpani kaalam
10% of cases naadi are present in Ilavenit kaalam
5% of cases naadi are present in Kaar kaalam.
5% of cases naadi are present in Koothir kaalam
2.5% of cases naadi are present in Mudhuvenit kaalam
Thesam
100% of cases naadi are present in Veppa Kaalam
159
Udal vanmai
57.5% of cases udal vanmai is Iyalpu
35% of cases udal vanmai is Melivu
7.5% of cases udal vanmai is Valivu
Nadiyin vanmai
77.5% of cases are present in Vanmai
22.5% of cases are present in Menmai
Naadi nadai
Azhalvali nadi is noted in 57.5% of cases
Valiazhal nadi is noted in 30% of cases
Azhaliyam nadi is noted in 10 % of cases
Iyavali nadi is noted in 2.5% of cases
Interpretation of Haemoglobin
100% of cases are present in Hb below 10g/dl
160
CONCLUTION
The aim of study is to evaluate the predominant Siddha parameters
observed in Paandu noi and compare with Modern parameters.
NILAM :-
Panndu noi is prominently afected 24 cases in Mullai nilam. In living peoples are
mostly affected in Piththa noi. By author observed this nilam is maybe the largest
occurance of piththa type of paandu noi.
5 cases are affected in Neithal nilam. In neithal nilam mostly vatha types of
paandu noi observed.
3 cases is affected in Kurinchi nilam. In Kurinchi nilam mostly kapha types of
paandu noi observed.
Naa – Suvai in
161
2. NIRAM :- By author observed in,
33 cases are present with veluppu niram. It is correlated with Kapha paandu
4 cases are present with manjal niram. It is correlated with Piththa paandu
3 cases are present with Karuppu niram. It is correlated with Vatha paandu
7. MOOTHTHIRAM
NEERKKURI - By author observed in,
39 cases are present in Manjal niram. It is correlated with the Piththa paandu noi.
01 case is present in Sivappu niram. It is correlated with the Piththa paandu noi.
162
02 cases are present in Muththu and 02 cases are present in Muththil Aravam.
There are correlated with the Kapha paandu noi.
163
BY AUTHOR OBSERVED IN THIS OVERALL STUDY
The following results are observed in Food habbit, Nilam, Sign and
symptoms, Envagaitheervugal, Udal thathukkal, Manikkadainool , Peripheral
smear , Blood grouping and other significant datas are help in taking the final
conclution in this clinical study.
164
6.0 SIDDHA TREATMENT OF ANAEMIA
kUj;Jtg; gupfhuk;
- jpUf;Fws;
165
mjpfupj;j gpj;jj;ij jd;dpiyg;gLj;j the;jp kUj;Jtk; nra;jy; Ntz;Lk;.
ghz;L Nehapy; Nehahsp NrhHthfTk;> jsHTlDk; ,Ug;gjhy; the;jp Kiw
kUj;JtkhdJ nfhLg;gjpy;iy.
Neha;ff
; hd fhuzq;fisj; jtpHf;f Ntz;Lk;.
LINE OF TREATMENT
ghz;L Nehapw;F kUj;JtkhdJ> FUjpapd; ePHg;ghfj;ijf; Fiwf;ff;
$baJk; gpj;jkhfpa jplg;nghUl;fis $l;lf;$baJkhd czitAk;
kUe;JfisAk; nfhLf;fNtz;Lk;.
jd;epiy khWgl;l Fw;wq;fis jd;epiyg;gLjJtjw;fhf fopr;ry;
kUe;Jfisf; nfhLf;f Ntz;Lk;. gpd;G grpj;jPiaj; J}z;Lk; kUe;JfNshL>
FUjpapd; td;ikiag; ngUf;fNtz;ba kUe;JfisAk; nfhLf;f Ntz;Lk;.
rpWePiuf; fopf;ff; $baJk;> vUf;fl;il jPHf;ff; $baJkhd FbePH> gw;gk;>
nre;J}uq;fis toq;f Ntz;Lk;.
nfhl;ilj; jpuhl;ir NrHe;j fopr;ry; kUe;Jfs;> mfj;jpf; fPiuf;FbePH>
epyhthiu NrHe;j FbePH> Nghd;w fopr;ry; FbePHfisf; nfhLj;j gp;d;G
grpj;jPiaj; J}z;Ltjw;fhd nghb tiffisj; Jiahff;
nfhz;L ,Uk;gpidg; gad;gLj;jp jahupf;fg;gl;l kUe;jfisg; gad;gLj;jp
kUj;Jtk; nra;jy; Ntz;Lk;
khJis kzg;ghF> rpwe;jJ
gpuhzhahkk;> rh;thq;fhrdk; Nghd;w Nahfhrdq;fs; > gpuzhahkk; vDk;
%r;Rg;gapw;rAk; rpwe;j ngWNgiwf; nfhLf;Fk;.
166
DIETARY REGIMEN
czT
; ”
CWgh by;iyA aph;fF
- jpUf;Fws;
ehk; cl;nfhs;Sk; czthdJ cliy td;ikg;gLj;jf;$bajhfTk;>
cliy fha fw;gkhf khw;wf;$bajhfTk; ,Uf;f Ntz;Lk;.
Neha; njhlf;fj;jpy; grpiaj;J}z;lf;$baJk;> clypd; FUjpia ngUf;ff;
$baJkhd czTg; nghUl;fis ngupJk; ifahsy; Ntz;Lk;.
czTk; vspjpy; nrupf;ff;$bajhfNt ,Uj;jy; Ntz;Lk;.
fPiufs;
fha;fwpfs;
goq;fs;
mirt tiffs;
NkYk;
gjhHj;j Fz tpsf;Fk;”
- itj;jpa rh];jpuk;
168
nghUs;:
169
BIBILIOGRAPHY
170
12. Uththamarayan., K.S, 2016: Siththa Maruththuvaankach surukkam. Indian
Medicine and Homeopathy Departmen, Chennai -600106. 88-135, 136-215,482-
582
13. Shanmugavelu, M., 2003: Noinaadalnoimuthalnaadal Thiratu. Part II, Indian
Medicine and Homeopathy Department, Tamil Nadu State Government ,
Arumbakkam Chennai- 600106.290-299.
14. Sivashanmugarasa., S., 2002: Siddha maruththuva moola thaththuvam. Siddha
Medical Development Society, 442,K.K.S Road, Jaffna, Srilanka. 71-74.
15. Thurairaasan., K., 2017: Noyilla Neri. Government central press, Chennai-
600079.183-191.
16. Thiyakaraajan., R., 2016: Kunapaadam- Thathu seeva vakuppu, Indian Medicine
and Homeopathy Departmen, Chennai -600106.89-104.
17. Murukesamuthaliyaar., K.S., 2013: Kunapaadam -Part I. Indian Medicine and
Homeopathy Departmen, Chennai -600106.2-4. 229-231,345-347
18. Ramachchndiran., S.P., 2000: Agasthiyar vaiyththiya sathkam. Thamarai
pathippakam, 7, NGO colloney, Vadapalani, Chennai.26.33.
19. Ramachchndiran., S.P., 2014: Agasthiyar vaiya raththina surukkam. Thamarai
pathippakam, 7, NGO colloney,vadapalani, Chennai.26.
20. Mickal aasaan., T., 2007: Agaththiyar piththa nithaanam. Rose offset, Karunkal,
Kanyakumari. 4-6.
21. Venkatraajan., S., Agasthiyar 2000 Part III. KR printers, Thanjaavoor,12-13.
22. Agasthiyamahamuni., 1992: Kurunaadi saasthiram 235. B. Raththina nayakar and
sons, Chennai 79. 7-3.
23. Agasthiyamahamuni., 1992: Agastiyamaamunivar paripooranam 400. Kurunaadi
saasthiram 235, B. Raththina nayakar and sons, Chennai 79. 7-3.
24. Saampasivampillai.,T.V., Tamil akaraathi
25. Praveen Agarvaal., George Mathew.,K.,2017: Medicine, Thomson press, India
ltd.5-8,35.
26. Alagappan., R., 2018; Manual of Practical Medicine. Jaypee Brothers Medical
publisher, bangaladesh. 482-489.
27. Mohan., Harsh., 2015: Text book of Pathology. Jaypee Brothers Medical
publisher, bangaladesh,301-303.
171
28. Park., K., 2017: Preventive and social medicine. Banarsidas bhanot
publishers,1167, Preme nagar, Jabalpur, 482001(MP), India.658 – 679.
29. Moni., A.S., 2012: Human anatomy and physiology. MB Thanukrishna, Maharaja
nagar, Thirunelvely. 627011. 109.
30. Ekaamparamuthaliyaar., S., 2018: Vaiyththiyathiravukol. Thirumakal vilasa
achchakam, Chennai – 600 079.4-10.
31. Kannusaamippillai., S., 2018: Sikichcharatnatheepam Vaiththiyasinthaamani.
Thirumakal vilasa achchakam, Chennai 600 079. 8-26.
32. Vadiveelumuthaliyaar., 2018: Gana veddiyaan. Thirumakal vilasa achchakam,
Chennai 600 079. 63-65.
33. Saravanamuththuppillai., V., 2016: Pathinene siththarkal Periya ganakkovai.
Thirumakal vilasa achchakam, Chennai 600 079.7-9.
34. Kanthasamy muthaliyaar., V., 2011: Aaviyalikkum amuthamuraichchurukkam.
Venkadeswara enterprises, Annasaalai, Chennai 600 002.31.
35. Munusaamy muthaliyaar., B., 2019: Moolikaimarmankal. Thirumalkal vilasa
achchakam, Chennai 600 079. 49,87.
36. Kannusaamyppillai., S., 2016: Vaiyiththiya raththinachchurukkam 360.
Thirumakal vilasa achchakam, Chennai 600 079. 1-8.
37. Inchasimuththuu.,S., 2018: Anubava siththamaruththuva muraikal. Thirumakal
vilasa achchakam, Chennai 600 079. 60-66.
38. Seeththaaraampirakash., B., 2014: Anubokavaiyththiya thevarakasiyam. A.R
Shah Printers, Chennai 600 005.388.
39. Palaraamaiah., V., 2010: Anubava siththavaithiyamuraikal. Aruljothy
pathippakam. Chennai.97.
40. Palarramaiah., V.,199.: Pathaarththakunapoothini. Aruljothy pathippakam.
Chennai.74.
41. Uthayakumaar., Padmaja.,2017: Medical Pharmacology. CBS Publishers &
distributors,Newdelhi 110 002, India.365-368.
42. Swaminathan.,K.,2010: Pathology & genetics for nurses- 2nd edition. Jaypee
brothers medical publishers(p)ltd, 306 -309.
43. Chaurasia’s., B.D, 2015:Human anatomy – Volume 2. CBS Publishers &
distributors,Newdelhi 110 002, India.336.
44. Sathyanarayanan., U., :Biochemistry.414-416
172
45. Sembulingam., K.,2010: Essential of medical Physiology -5th edition. 76 – 79.
173
51
52
PG NOINADAL DEPARTMENT
GOVERNMENT SIDDHA MEDICAL COLLEGE PALAYAMKOTTAI .
A CLINICAL STUDY ON DIAGNOSTIC METHODOLOGY OF PAANDU THROUGH SIDDHA
PARAMETERS
1. O.P.NO :……………………………………
2. S.No …………………………………….
3. Date …………………………………….
4. Name …………………………………….
5. Age …………………………………….
6. Sex …………………………………….
RESULT
1. Diagnosis …………………………….
2. Neikkuri ……………………………...
3. Nadi ……………………………...
4. Manikkadai Nool ……………………………..
5. Blood Group ……………………………
6. Peripheral Smear …………………………….
c. Manneral (Spleen)
d. Puppusam (Lungs)
e. irudhayam( Heart)
f. Pirukkam(Kidney)
g. Moolai (Brain)
NEIKKURI
a. Aravam v Moththiram v Muththu v
b. Aravil mothiram Aravil muththu v Mothiraththil Aravam v
v
c. Mothiraththil muththu v Muththil Aravam v Muththil Aravam v
d. Muththil mothiram v Asaththiyam v Melenna paraval v
H. NAADI
a. Kaalam v Kaarkaalam v Koothirkaalam v Munpanikaalam v
b. Pinpanikaalam v Ilavenirkaalam v Mudhuvenirkaalam
v
c. Desam v
Kulir v Veppam v
d. Udal Vanmai v Iyyalpu v Valivu v Melivu v
e. Naadyin Vanmai v Vanmai v Menmai v
f. NaadiNadai v Vali v Azhal v Iyam v
Valiazhal v
v
28. MANIKKADAINOOL
33. URINE
a. ALBUMIN :- …………………………………….
b. SUGAR :- …………………………………….
c. DEPOSITES :-……………………………………...
mur rpj;jkUj;Jtf;fy;Y}up> ghisaq;Nfhl;il> jpUney;Ntyp
gl;l Nkw;gbg;G Neha;ehly; Jiw> “ghz;L” Neha; fzpg;G Kiw kw;Wk; FwpFzq;fis
gw;wpa XH Ma;T Nehahspapd; jfty; gbtk;
Ma;TKiw
NeUk; cghijfs;
ek;gfj;jd;ik
gl;l Nkw;gbg;G Neha;ehly; Jiw> “ghz;L” Neha; fzpg;G Kiw kw;Wk; FwpFzq;fis
gw;wpa XH Ma;T Nehahspapd; jfty; gbtk;
jpfjp : ifnahg;gk;
,lk; ngaH
Nehahspapd; xg;Gjy;
ehd; ,e;j Ma;tpd; NghJ fhuzk; vJTk; $whky;> vg;nghOJ Ntz;LkhdhYk; ,e;j
Ma;tpypUe;J tpLtpj;Jf; nfhs;Sk; cupikiag; ngWfpd;Nwd;.
jpfjp : ifnahg;gk; :
,lk; : ngaH :
GOVT SIDDHA HOSPITAL – PALAYAMKOTTAI DEPARTMENT OF
NOINAADAL THROUGH SIDDHA PARAMETERS
FORM IV A
I have been informed about the study to my satisfaction by the attending investigator and
the purpose of this trial and the nature of study and the laboratory investigations. I also give my
consent to publish my urine sample photographs in scientific conference and reputed scientific
journals for the betterments of clinical research
I am also aware of my right to OPT out of the trial at any time during the course of the trial
without having to give the reason for doing so.
Date :
Date :
Date :
Scanned by CamScanner
Scanned by CamScanner
Scanned by CamScanner
Scanned by CamScanner
Scanned by CamScanner
Scanned by CamScanner
Scanned by CamScanner
Scanned by CamScanner
Scanned by CamScanner